Light Mode
$0.0004 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0004, and at the day’s high of $0.0006
-0.28 (-99.86%) / 6M
Momentum, market sentiment, and recent alerts
ADTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -99.8%.
No alerts for ADTX in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Mountain View, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.